The drug "Stresam". Instructions for use and description

Medication "Stresam" instructions for use defines as an anxiolytic agent containing etifoksina hydrochloride. The drug can be used as a daytime tranquilizer, because it does not affect the speed of psychomotor reactions. In addition, the drug Strezam is not addictive.

Pharmacological properties

Ethifoxine hydrochloride affects the GABA-ergic system, neutralizes a sense of fear and anxiety, reduces emotional tension. After ingestion, the drug is absorbed in the intestine quite well, forms a pharmacologically active metabolite in the body. Within one or two hours, the highest plasma concentration is achieved. The agent is excreted in three stages mainly by the kidneys.

Indications for the prescription of the drug Stresam

Instructions for use indicate that the drug is used in the treatment of patients with stress-induced neurasthenic conditions, accompanied by unreasonable anxiety, anxiety, fear, phobic disorders, decreased activity, apathy, vegetative disorders.

Form of issue. Composition

The drug is given in the form of capsules intended for oral administration. They are packaged in 12 pieces per cell pack. One cardboard bundle includes two or five such plates. In one capsule, etofoxine hydrochloride is contained in an amount of 50 mg. The composition also includes additional ingredients, including lactose monohydrate.

Method of using the drug Stresam

Instructions for use show that the capsules should be swallowed whole, while washing with water in small amounts. It is advisable to drink the medicine before eating. Dosage and duration of the therapeutic course should be established by the doctor in accordance with the nature of the pathology. The recommended dose is 1 capsule twice or thrice a day. The duration of the course of treatment is 1-3 months. After stopping the use of the drug Strozam instructions for use (the reviews also confirm) do not notice the development of withdrawal syndrome.

Adverse events

As a rule, the patient tolerates the medication well. Individual patients complained of dizziness when taking the drug, especially at the initial stages of therapy. However, a similar symptom over time passed independently. In the case of the presence of hypersensitivity to etifoksina hydrochloride, skin allergic reactions may develop.

Contraindications

The Strezam tool prohibits the use of glucose-galactose, galactosemia, and lactose deficiency in patients with a malabsorption syndrome . In addition, the drug should not be prescribed to patients with shock conditions, impaired functioning of the kidney and liver of a pronounced character, myasthenia gravis. In pediatric practice, Strezam is not used, nor is it used in the treatment of women in a state of pregnancy and during the lactation period.